Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis

PURPOSE: Approximately 6% of patients with rheumatoid arthritis (RA) in the USA have refractory disease that is resistant to standard-of-care therapies. A recent phase IV clinical trial affirmed the safety and efficacy of repository corticotropin injection (RCI; Acthar® Gel) for refractory RA. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Hayes, Kyle, Ahn, Sung-Woo, Wan, George J., Panaccio, Mary P., Karlsson, Daniel, Furst, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964863/
https://www.ncbi.nlm.nih.gov/pubmed/34919213
http://dx.doi.org/10.1007/s40744-021-00412-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964863/
https://www.ncbi.nlm.nih.gov/pubmed/34919213
http://dx.doi.org/10.1007/s40744-021-00412-x

Ejemplares similares